NEUROCONTRA Neuroimaging the effects of oral contraceptives on the female brain
- Coordinator
- Paris-Lodron-Universitat Salzburg, Austria
- Runs
- 1 October 2025 to 30 September 2027
- Status
- Ended early
- EU funding
- €214k
- Total cost
- —
- Partners
- 2 organisations in 2 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101207460
What the project is doing
In the project's own words, from its summary on CORDIS.
The contraceptive pill has been widely used for over six decades and is one of the most frequently used hormonal contraceptive methods, with approximately 151 million users worldwide. Despite its use, research into its effects on the female brain remains limited, primarily due to historical underfunding and the novelty nature of this research area. The NEUROCONTRA project aims to address this knowledge gap through an innovative, multidisciplinary approach that combines neuroimaging, theoretical neuroscience, neuroendocrinology, and machine learning.
This research will pioneer applying advanced whole-brain dynamics analyses to a large-sample neuroimaging dataset, encompassing cross-sectional and longitudinal data from adolescent and adult women. By examining the effects of hormonal contraceptives on brain dynamics across multiple spatiotemporal scales, NEUROCONTRA aims to establish a unifying framework for understanding the changes in brain function induced by contraceptives.
The findings could significantly enhance our understanding of the complex interactions between hormonal contraceptives and the female brain, with important implications for neuroscience, clinical practices, societal awareness, and women's rights.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Paris-Lodron-Universitat Salzburg | Salzburg | Austria | Coordinator |
| Universidad Pompeu Fabra | Barcelona | Spain | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI